Literature DB >> 12441278

[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].

Roland Bugat1, Anne Bataillard, Thierry Lesimple, Jean-Jacques Voigt, Stéphane Culine, Alain Lortholary, Yacine Merrouche, Gérard Ganem, Marie-Christine Kaminsky, Sylvie Negrier, Maurice Perol, Céline Laforêt, Pierre Bedossa, Gérard Bertrand, Jean-Michel Coindre, Karim Fizazi.   

Abstract

CONTEXT: The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of French Cancer Centers (FNCLCC), the 20 French Cancer Centers, and specialists from French Public Universities, General Hospitals and Private Clinics. The main objective is the development of clinical practice guidelines to improve the quality of health care and the outcome of cancer patients. The methodology is based on a literature review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery.
OBJECTIVES: To develop clinical practice guidelines for carcinoma of unknown primary site (CUPS) patients according to the definitions of the Standards, Options and Recommendations project.
METHODS: Data were identified by searching Medline , web sites, and using the personal reference lists of members of the expert groups. Once the guidelines were defined, the document was submitted for review to 81 independent reviewers.
RESULTS: The main recommendations for the management of patients CUPS are presented below: 1) An adapted immunochemistry test using a specific antibody battery should be performed for the anatomopathologic diagnosis. 2) The aim of the diagnosis is to identify specific anatomoclinical forms that can be treated by a specific treatment (standard, level of evidence B2). Except these forms, searching for the primary tumor site have no prognosis or therapeutic interest that can justify a systematic diagnosis assessment (standard, level of evidence B2). 3) The management of poorly differentiated neuroendocrine carcinoma consists of platin/etoposide based chemotherapy. There is no standard treatment for the differentiated forms. 4) Surgical node excision and adjuvant radiotherapy should be performed in case of epidermoid carcinoma with cervical node metastases. In the event of a non operable tumor, an irradiation should be performed. 5) The management of axillary node metastases in women with adenocarcinoma should be the same as the management of patients with lymph node metastases in breast cancer. If mammary MRI is negative, surgical treatment and mammary irradiation are not recommended and an axillary node excision should be performed. 6) The standard treatment for women with primary papillary serous carcinoma of the peritoneum is a surgical resection followed by chemotherapy, as recommended for ovarian cancer. 7) CUPS not belonging to any specific anatomoclinical forms can be treated by chemotherapy, symptomatic treatment alone or treatment based on biphosphonates in presence bone metastases.

Entities:  

Mesh:

Year:  2002        PMID: 12441278

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  6 in total

Review 1.  Diagnosis and management of neck metastases from an unknown primary.

Authors:  L Calabrese; B A Jereczek-Fossa; J Jassem; A Rocca; R Bruschini; R Orecchia; F Chiesa
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

2.  Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival.

Authors:  Miloslav Pala; Pavla Novakova; Zdena Pechacova; Lucie Vesela; Antonin Vrana; Jarmila Sukova; Petra Holeckova; Tereza Drbohlavova; Tomas Podlesak; Lubos Petruzelka
Journal:  Strahlenther Onkol       Date:  2022-08-09       Impact factor: 4.033

3.  A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report.

Authors:  Takeshi Todoroki; Souichiro Murata; Yuji Nakagawa; Nobuhiro Ohkohchi; Yukio Morishita
Journal:  Int Semin Surg Oncol       Date:  2006-08-25

4.  Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002).

Authors:  R Bugat; A Bataillard; T Lesimple; J J Voigt; S Culine; A Lortholary; Y Merrouche; G Ganem; M C Kaminsky; S Negrier; M Perol; C Laforêt; P Bedossa; G Bertrand; J M Coindre; K Fizazi
Journal:  Br J Cancer       Date:  2003-08       Impact factor: 7.640

5.  Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary.

Authors:  Yazan Abu-Shama; Julia Salleron; Florent Carsuzaa; Xu-Shan Sun; Carole Pflumio; Idriss Troussier; Claire Petit; Matthieu Caubet; Arnaud Beddok; Valentin Calugaru; Stephanie Servagi-Vernat; Joël Castelli; Jessica Miroir; Marco Krengli; Paul Giraud; Edouard Romano; Jonathan Khalifa; Mélanie Doré; Nicolas Blanchard; Alexandre Coutte; Charles Dupin; Shakeel Sumodhee; Yungan Tao; Vincent Roth; Lionel Geoffrois; Bruno Toussaint; Duc Trung Nguyen; Jean-Christophe Faivre; Juliette Thariat
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

Review 6.  Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin.

Authors:  Maria V Barbolina
Journal:  Pharmacol Res       Date:  2021-03-30       Impact factor: 10.334

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.